The World of Health & Medicine News

Can physical activity increase life expectancy in older adults?

Can physical activity increase life expectancy in older adults?

A review article published in the Canadian Medical Association Journal summarizes a growing body of evidence supporting the important role of physical activity in preventing or reducing the effects of disease.

Canada’s population is aging, with at least one in five people expected to be 65 years of age or older by 2025, and the number of people over 85 expected to triple in the next 20 years. However, for many, these added years do not translate into healthy years. More than 80 per cent of adults do not meet the Canadian government’s physical activity recommendations.

Physical activity is one of the most important ways to maintain or improve functional independence, including among seniors who are frail or at risk of falling. High levels of physical activity in older age are associated with improved cognition, mental health and quality of life.

A 2023 meta-analysis of several large studies found that 150 minutes of moderate physical activity per week reduced the risk of death from disease by 31%. Physical activity is essential as we age and can help prevent or reduce the risk of more than 30 chronic diseases, including coronary artery disease, heart failure, type 2 diabetes, chronic obstructive pulmonary disease, osteoporosis, depression, dementia, and cancer.

spot_img

Explore more

spot_img

New lasso-shaped antibiotic kills drug-resistant bacteria

New lasso-shaped antibiotic kills drug-resistant bacteria Researchers at McMaster University have identified a new molecule with antibiotic activity against a range of disease-causing bacteria, including...

Chinese brain chip project speeds up human trials after first success

Chinese brain chip project speeds up human trials after first success A tie-up between a Chinese research institute and tech company said on Monday that...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by 94 percent According to results published in the New England Journal of Medicine: In a...

Novo Nordisk to license obesity drug from Lexicon in up to...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O),...

Vykat XR approved for genetic binge eating disorder

For the first time/ Vykat XR approved for genetic binge eating disorder The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics’ drug to...

Keytruda subcutaneous injection to launch on October 1

Keytruda subcutaneous injection to launch on October 1 Merck & Co. said Thursday it plans to launch a subcutaneous injection of its best-selling cancer immunotherapy,...

Buying an autoimmune disease drug for $1.3 billion

Sanofi/ Buying an autoimmune disease drug for $1.3 billion Sanofi announced Thursday that it has agreed to buy the biopharmaceutical company’s autoimmune disease drug Dren Bio...

US FDA approves Sanofi’s bleeding disorder therapy

US FDA approves Sanofi's bleeding disorder therapy The U.S. Food and Drug Administration approved French drugmaker Sanofi's (SASY.PA), opens new tab hemophilia therapy, introducing a new...